会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Penem derivatives and antimicrobial agent containing the same
    • Penem衍生物和含有相同的抗微生物剂
    • US20050004092A1
    • 2005-01-06
    • US10831694
    • 2004-04-26
    • Masaji IshiguroTakashi NakatsukaRie TanakaKoshi NamikawaShinsuke Matsuki
    • Masaji IshiguroTakashi NakatsukaRie TanakaKoshi NamikawaShinsuke Matsuki
    • C07D499/74C07D499/88A61K31/43
    • C07D499/88Y02P20/55
    • A penem derivative represented by the following formula (I): wherein R1 represents a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted alkylthio group, a substituted or unsubstituted alkenylthio group, a substituted or unsubstituted aralkylthio group, a substituted or unsubstituted arylthio group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted heterocyclic thio group, a substituted or unsubstituted acylthio group, a mercapto group or a hydrogen atom, and R2 represents a hydrogen atom or a carboxyl-protecting group; or a pharmacologically acceptable salt thereof. The compound (I) exhibits strong antibacterial activities, and especially, shows strong activities against MRSA. It is therefore useful not only as a general antibacterial agent but also as an antibacterial agent for MRSA against which no general antibacterial agents are recognized to be-effective.
    • 由下式(I)表示的pen嗪衍生物:其中R1表示取代或未取代的烷基,取代或未取代的烯基,取代或未取代的芳烷基,取代或未取代的芳基,取代或未取代的烷硫基, 取代或未取代的链烯硫基,取代或未取代的芳烷硫基,取代或未取代的芳硫基,取代或未取代的杂环基,取代或未取代的杂环硫基,取代或未取代的酰硫基,巯基或氢原子 R 2表示氢原子或羧基保护基; 或其药理学上可接受的盐。 化合物(I)表现出强烈的抗菌活性,特别是对MRSA具有较强的活性。 因此,不仅可以作为一般的抗菌剂,而且作为MRSA的抗菌剂也是有用的,其中没有一般的抗菌剂被认为是有效的。
    • 2. 发明授权
    • Penem derivatives, their preparation and pharmaceutical compositions
containing them
    • Penem衍生物,它们的制备和含有它们的药物组合物
    • US5747483A
    • 1998-05-05
    • US414081
    • 1995-03-17
    • Maria AltamuraFederico Maria ArcamoneEnzo PerrottaVittorio PestelliniPiero SbraciGiuseppe Cascio
    • Maria AltamuraFederico Maria ArcamoneEnzo PerrottaVittorio PestelliniPiero SbraciGiuseppe Cascio
    • C07D499/88A61K31/43A61K31/48A61P31/04C07D499/883C07D499/897C07D499/861
    • C07D499/88
    • Penem derivatives of general formula (I), below, and pharmaceutically acceptable salts thereof are disclosed. ##STR1## wherein: R.sub.1 is H, C.sub.1 -C.sub.6 alkoxy, C.sub.3 -C.sub.7 cycloalkyl, or an optionally protected C.sub.1 -C.sub.6 hydroxyalkyl; R.sub.2 is a free or esterified carboxyl group or a carboxylate anion; R.sub.3 is H or C.sub.1 -C.sub.6 alkyl; R.sub.4 is H, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 hydroxyalkyl, C.sub.1 -C.sub.6 mercaptoalkyl, C.sub.1 -C.sub.6 aminoalkyl, C.sub.1 -C.sub.6 alkyl substituted by a quaternary ammonium group, C.sub.1 -C.sub.6 carboxyalkyl, cycloalkyl, aryl, arylalkyl, heterocyclyl-alkyl optionally substituted, saturated or unsaturated heterocycle, or R.sub.3 and R.sub.4 are linked together to form a heterocyclic ring having 3-7 atoms; R.sub.5 and R.sub.6 independently are H, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 hydroxyalkyl, C.sub.1 -C.sub.6 mercaptoalkyl, C.sub. -C.sub.6 aminoalkyl, alkenyl, cycloalkyl, aryl, arylalkyl, alkylaryl, heterocyclyl-alkyl, C.sub.1 -C.sub.6 alkyl carboxyamide, or R.sub.5 and R.sub.6 are taken together to form a heterocyclic ring having 3-7 atoms, and n is an intiger from 1 to 3.
    • 公开了下述通式(I)的苦味衍生物及其药学上可接受的盐。 (I)其中:R 1是H,C 1 -C 6烷氧基,C 3 -C 7环烷基或任选保护的C 1 -C 6羟烷基; R2是游离的或酯化的羧基或羧酸根阴离子; R3是H或C1-C6烷基; R4是H,C1-C6烷基,C1-C6羟基烷基,C1-C6巯基烷基,C1-C6氨基烷基,被季铵基团取代的C1-C6烷基,C1-C6羧基烷基,环烷基,芳基,芳基烷基, 取代的饱和或不饱和杂环,或者R 3和R 4连接在一起形成具有3-7个原子的杂环; R5和R6独立地是H,C1-C6烷基,C1-C6羟基烷基,C1-C6巯基烷基,C-C6氨基烷基,烯基,环烷基,芳基,芳基烷基,烷基芳基,杂环基 - 烷基,C1-C6烷基羧酰胺或R5和 R6一起形成具有3-7个原子的杂环,并且n是1至3的酸酐。
    • 5. 发明授权
    • Process for removal of allyl group or allyloxycarbonyl group
    • 除去烯丙基或烯丙氧基羰基的方法
    • US5621084A
    • 1997-04-15
    • US417285
    • 1995-04-03
    • Msanori HondaHiromasa MoritaIsao Nagakura
    • Msanori HondaHiromasa MoritaIsao Nagakura
    • B01J31/02B01J31/18B01J31/22B01J31/24C07B41/02C07B43/04C07C209/62C07C269/06C07D499/00C07D499/88C07D501/00C07H9/04C07H1/06C07C29/10C07C41/00C07K1/00
    • C07D499/00B01J31/185B01J31/2239B01J31/2404C07B41/02C07B43/04C07C209/62C07C269/06C07D499/88C07D501/00C07H9/04B01J2531/824B01J31/2282
    • This invention relates to a process for the removal of an allyl or allyloxycarbonyl group from an allyl or allyloxycarbonyl group protected compound (such as an allylic ester, carbonate, carbamate, O-allyl derivatives or N-allyl derivatives), which comprises contacting the allyl or allyloxycarbonyl group protected compound with a sulfinic acid compound, in the presence of a palladium catalyst in a reaction-inert solvent. Preferably, the sulfinic acid compound is represented by the formula:X--SO.sub.2 M (I)wherein X is C.sub.1-20 alkyl, substituted C.sub.1-20 alkyl (wherein the substituent(s) are independently halo, nitro, sulfo, oxo, amino, cyano, carboxy, hydroxy or moieties derived therefrom), phenyl, substituted phenyl (wherein the substituent(s) are independently C.sub.1-3 alkyl, halo nitro, sulfo, oxo, amino, cyano, carboxy, hydroxy, acetamido or moieties derived therefrom), furyl or thienyl; and M is hydrogen, an alkali metal or ammonium salt residue. Of these, most preferred sulfinic acid compound is lithium p-toluenesulfinate, sodium p-toluenesulfinate, potassium p-toluenesulfinate, p-toluenesulfinic acid, ammonium p-toluenesulfinate, lithium benzenesulfinate, sodium benzenesulfinate, potassium benzenesulfinate, benzenesulfinic acid or ammonium benzenesulfinate. This invention is well suited to a process for the conversion of an allyl ester of 5R,6S-6-(1R-hydroxyethyl)-2-(1R-oxo-3S-thiolanylthio)-2-penem-3-carboxylic acid to 5R,6S-6-(1R-hydroxyethyl)-2-(1R-oxo-3S-thiolanylthio)-2-penem-3-carboxylic acid.
    • 本发明涉及从烯丙基或烯丙氧基羰基保护的化合物(例如烯丙基酯,碳酸酯,氨基甲酸酯,O-烯丙基衍生物或N-烯丙基衍生物)中除去烯丙基或烯丙氧基羰基的方法,该方法包括使烯丙基 或烯丙氧基羰基保护的化合物与亚磺酸化合物在钯催化剂存在下在反应惰性溶剂中反应。 优选地,亚磺酸化合物由下式表示:X-SO 2 M(I)其中X是C 1-20烷基,取代的C 1-20烷基(其中取代基独立地是卤素,硝基,磺基,氧代,氨基, 氰基,羧基,羟基或由其衍生的部分),苯基,取代的苯基(其中取代基独立地为C 1-3烷基,卤代硝基,磺基,氧代,氨基,氰基,羧基,羟基,乙酰氨基或由其衍生的部分) ,呋喃基或噻吩基; M为氢,碱金属或铵盐残基。 其中最优选的亚磺酸化合物是对甲苯亚磺酸锂,对甲苯亚磺酸钠,对甲苯亚磺酸钾,对甲苯亚磺酸,对甲苯亚磺酸铵,苯亚磺酸锂,苯亚磺酸钠,苯亚磺酸钾,苯亚磺酸或苯亚磺酸铵。 本发明非常适用于将5R,6S-6-(1R-羟乙基)-2-(1R-氧代-3S-硫杂环戊基硫代)-2-青霉烯-3-羧酸的烯丙酯转化成5R ,6S-6-(1R-羟乙基)-2-(1R-氧代-3S-硫杂环戊基硫代)-2-青霉烯-3-羧酸。
    • 6. 发明授权
    • Carbapenem
    • 卡巴培南
    • US5614624A
    • 1997-03-25
    • US460209
    • 1995-06-02
    • Koichi HiraiYuji IwanoTakahide NishiAkira YoshidaKozo OdaHiroo Koyama
    • Koichi HiraiYuji IwanoTakahide NishiAkira YoshidaKozo OdaHiroo Koyama
    • C07D205/08C07D401/12C07D403/12C07D477/02C07D477/04C07D477/20C07D499/88C07F7/10C07F7/18C07D487/04
    • C07D401/12C07D205/08C07D403/12C07D477/02C07D477/04C07D477/20C07D499/88C07F7/10C07F7/186C07F7/1892Y02P20/55
    • A compound of the formula ##STR1## in which: R.sup.1' is hydrogen or a carboxy-protecting group;R.sup.41' is hydrogen or a hydroxy-protecting group;R.sup.42' is a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy, a halogen, an aryl or an aryloxy; R.sup.43' is hydrogen, a C.sub.1 -C.sub.6 alkyl, a C.sub.1 -C.sub.6 alkoxy, a hydroxy, a halogen, a cyano, a nitro or a group of the formula --NR.sup.8' R.sup.9', where R.sup.8' and R.sup.9' are independently selected from the group consisting of hydrogen, amino-protecting groups, C.sub.1 -C.sub.6 alkyl groups and phenyl groups, or R.sup.8' and R.sup.9' together represent a group --(CH.sub.2).sub.q '--O.sub.r '--(CH.sub.2).sub.s '--, where q' and s' are independently 0 or an integer of from 1 to 5 and r' is 0 or 1, provided that (q'+s') is an integer of at least 2; R.sup.45' and R.sup.46' are independently selected from the group consisting of C.sub.1 -C.sub.6 alkyl groups and aryl groups, or R.sup.45' and R.sup.46' together represent a group --(CH.sub.2).sub.q '--O.sub.r '--(CH.sub.2).sub.s '--, where q' and s' are independently 0 or an integer of from 1 to 5 and r' is 0 or 1; Y' is oxygen or sulfur; and j' is 0, 1 or 2.
    • 式(IV')的化合物,其中:R1'是氢或羧基保护基; R 41'是氢或羟基保护基; R 42'是C 1 -C 6烷基,C 1 -C 6烷氧基,卤素,芳基或芳氧基; R 43'是氢,C 1 -C 6烷基,C 1 -C 6烷氧基,羟基,卤素,氰基,硝基或式-NR 8'R 9'基团,其中R 8'和R 9'独立地选自 由氢,氨基保护基,C 1 -C 6烷基和苯基组成的组,或者R 8'和R 9'一起表示基团 - (CH 2)q'-Or' - (CH 2)s',其中q' 和s'独立地为0或1至5的整数,r'为0或1,条件是(q'+ s')为至少2的整数; R 45'和R 46'独立地选自C 1 -C 6烷基和芳基,或者R 45'和R 46'一起表示基团 - (CH 2)q'-Or' - (CH 2)s - ,其中 q'和s'独立地为0或1至5的整数,r'为0或1; Y'是氧或硫; 并且j'为0,1或2。